1don MSN
Contrarius Global Equity Fund’s Thoughts on CRISPR Therapeutics’ (CRSP) Gene Editing Therapy
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while ...
AZoLifeSciences on MSN
CRISPR for Christmas? The year’s biggest gene editing breakthroughs, unwrapped
In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...
Morning Overview on MSN
New CRISPR leap could transform treatment for genetic diseases
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Blockchain, nanomedicine, and 3D printing signal a growing emphasis on improving healthcare delivery through innovative ...
The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented ...
After years of research, scientists in China have created a bone-free fish, which has been named 'Zhongke No. 6'. The new ...
Corynebacterium glutamicum S9114, a superior strain widely used in glutamic acid industrial production through traditional mutagenesis screening, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback